» Articles » PMID: 6107116

The Effects of Clobazam and Lorazepam on Aspects of Psychomotor Performance and Car Handling Ability

Overview
Specialty Pharmacology
Date 1980 Aug 1
PMID 6107116
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

1 Laboratory tests of psychomotor performance and 'on road' assessments of car handling ability were made following repeated doses of clobazam 10 mg three times daily, lorazepam 1 mg three times daily and matching placebo 1 capsule three times daily. 2 Both active compounds produced on impairment, compared to placebo, in some mental arithmetic and letter cancellation tasks, but these effects were neither widespread nor consistent. 3 Lorazepam produced a significant impairment of car driving tasks and analogue rating scales of subjective alertness. The pronounced sedative activity of the drug was also shown in the verbal reports of side effects and in indices of early morning sedation derived from the Leeds Sleep Evaluation Questionnaire. 4 Clobazam did not produce either the objective, or the subjective impairment of performance and alertness found with lorazepam. 5 The results taken as a whole show important differences between the 1,4 benzodiazepine, lorazepam, and the 1,5 benzodiazepine, clobazam, in their effects on the integrity of psychomotor performance related to car driving ability.

Citing Articles

A scoping review of motor vehicle operator performance assessments for benzodiazepine receptor agonists.

Murphy A, Sawires K, Peltekian S, Helwig M, Macdonald M, Martin-Misener R Explor Res Clin Soc Pharm. 2024; 16:100538.

PMID: 39634377 PMC: 11615539. DOI: 10.1016/j.rcsop.2024.100538.


Nonbenzodiazepine hypnotics and police-reported motor vehicle crash risk among older adults: a sequential target trial emulation.

Zullo A, Khan M, Pfeiffer M, Margolis S, Ott B, Curry A Am J Epidemiol. 2024; 194(3):662-673.

PMID: 38957996 PMC: 11879583. DOI: 10.1093/aje/kwae168.


Subjective assessment of acute mountain sickness: investigating the relationship between the Lake Louise Self-Report, a visual analogue scale and psychological well-being scales.

Fruhauf A, Burtscher M, Pocecco E, Faulhaber M, Kopp M Springerplus. 2016; 5(1):1646.

PMID: 27722064 PMC: 5033803. DOI: 10.1186/s40064-016-3313-z.


Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review.

Rudisill T, Zhu M, Kelley G, Pilkerton C, Rudisill B Accid Anal Prev. 2016; 96:255-270.

PMID: 27569655 PMC: 5045819. DOI: 10.1016/j.aap.2016.08.001.


Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.

De Leon J, Spina E, Diaz F Ther Drug Monit. 2013; 35(1):30-47.

PMID: 23318278 PMC: 3546316. DOI: 10.1097/FTD.0b013e31827ada88.


References
1.
Knowles J, COMER W, RUELIUS H . Disposition of 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam) in humans. Determination of the drug by electron capture gas chromatography. Arzneimittelforschung. 1971; 21(7):1055-9. View

2.
ELLIOTT H, NOMOF N, Navarro G, RUELIUS H, Knowles J, COMER W . Central nervous system and cardiovascular effects of lorazepam in man. Clin Pharmacol Ther. 1971; 12(3):468-81. DOI: 10.1002/cpt1971123468. View

3.
Norris W, Wallace P . Wy 4036 (lorazepam): a study of its use in premedication. Br J Anaesth. 1971; 43(8):785-9. DOI: 10.1093/bja/43.8.785. View

4.
Hedges A, Turner P, Harry T . Preliminary studies on the central effects of lorazepam, a new benzodiazepine. J Clin Pharmacol New Drugs. 1971; 11(6):423-7. View

5.
Harry T, Richards D . Lorazepam--a study in psychomotor depression. Br J Clin Pract. 1972; 26(8):371-3. View